Literature DB >> 19748110

Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.

Chi-Yao Chang1, Pinwen Peter Chiou, Wei-Jung Chen, Yu-Hui Li, Jinn-Chin Yiu, Yeong-Hsiang Cheng, Su-Der Chen, Chung-Tien Lin, Yu-Shen Lai.   

Abstract

Three canine mammary tumor (CMT) cell lines, namely DE-E, DE-F and DE-SF, have been established from a surgically excised specimen of a malignant mammary tumor. These CMT cell lines have been cultured for over 200 passages. The cell doubling time was estimated to be approximately 30 h for all three cell lines. DE-E, DE-F and DE-SF were epithelial, fibroblast and spindle fibroblast in morphology, respectively. Under electron microscope, DE-F and DE-SF cells displayed a higher nucleus/cytoplasm ratio as compared with DE-E. Variation in chromosome number was also observed in the three cell lines. In addition to the morphological characteristics, these cell lines displayed differential patterns of several known mammary tumor cell markers. Following xenotransplantation of the CMT cells into nude mice, DE-F and DE-SF developed tumors within 2 weeks, whereas DE-E failed to develop any visible tumor up to 8 weeks after injection. Lastly, the CMT cell lines exhibited differential chemoresistance to several anti-tumor drugs, including melatonin, cyclosporine A, tamoxifen and indole, suggesting that these cell lines can be used as a comparative experimental model for the tumorigenesis of mammary carcinomas and a valuable tool for anti-cancer drug screening. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748110     DOI: 10.1016/j.rvsc.2009.08.006

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

1.  Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.

Authors:  Yen-Ling Hsiao; Tai-Zu Hsieh; Chian-Jiun Liou; Yeong-Hsiang Cheng; Chung-Tien Lin; Chi-Yao Chang; Yu-Shen Lai
Journal:  BMC Vet Res       Date:  2014-09-30       Impact factor: 2.741

2.  Effects of Tyrosine Kinase Inhibitor-masitinib Mesylate on Canine Mammary Tumour Cell Lines.

Authors:  Fulya Ustun-Alkan; Tülay Bakırel; Oya Üstüner; Ceren Anlas; Suzan Cinar; Funda Yıldırım; Aydın Gürel
Journal:  J Vet Res       Date:  2021-07-24       Impact factor: 1.744

Review 3.  In vitro comparative models for canine and human breast cancers.

Authors:  Simona Visan; Ovidiu Balacescu; Ioana Berindan-Neagoe; Cornel Catoi
Journal:  Clujul Med       Date:  2016-01-15

4.  Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo.

Authors:  Patrícia de Faria Lainetti; Andressa Brandi; Antonio Fernando Leis Filho; Maria Carolina Mangini Prado; Priscila Emiko Kobayashi; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Front Vet Sci       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.